Trial Profile
A pretreatment drug resistance surveillance study on the prevalence of resistance mutations to etravirine and rilpivirine in HIV-infected patients starting ART in Argentina
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Rilpivirine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 30 Dec 2016 New trial record